EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Design of Bayesian Clinical Trials With Clustered Data

Luke Hagar iD, Shirin Golchi iD

Statistics in Medicine · 2026

DOI: 10.1002/sim.70488 ↗

At a glance

Journal article in Statistics in Medicine, 2026. Written by Luke Hagar and 1 co-authors. Institution: Clinical Trials Capability, The University of Queensland, Brisbane, Queensland, Australia. Major MEDLINE topics: Randomized Controlled Trials as Topic, Research Design, Clinical Trials as Topic. 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Natural Sciences and Engineering Research Council of Canada, Fonds de Recherche du Québec - Santé, Canadian Statistical Sciences Institute.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

In the design of clinical trials, it is essential to assess the design operating characteristics (e.g., power and the type I error rate). Common practice for the evaluation of operating characteristics in clinical trials that employ Bayesian analysis and decision procedures relies on estimating the sampling distribution of posterior summaries via Monte Carlo simulation. It is computationally intensive to repeat this estimation process for each design configuration considered, particularly for clustered data that are analyzed using complex, high‐dimensional models. In this paper, we propose an efficient method to assess operating characteristics and determine sample sizes for Bayesian trials with clustered data. We prove theoretical results that enable posterior probabilities to be modeled as a function of the number of clusters. Using these functions, we assess operating characteristics at a range of sample sizes given simulations conducted at only two values for the number of clusters. These theoretical results are also leveraged to quantify the impact of simulation variability on our sample size recommendations. The applicability of our methodology is illustrated using an example Bayesian cluster‐randomized clinical trial.

Subjects

MeSH terms (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignClinical Trials as TopicBayes TheoremHumansSample SizeCluster AnalysisMonte Carlo MethodComputer SimulationModels, Statistical

Author keywords

cluster‐randomized trialsexperimental designlongitudinal studiesmarginal estimandsposterior probabilitiessample size determination

Authors and institutions

  • Clinical Trials Capability, The University of Queensland, Brisbane, Queensland, Australia.
  • Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada.

ORCID profiles: Luke Hagar, Shirin Golchi

Funding

  • Natural Sciences and Engineering Research Council of Canada
  • Fonds de Recherche du Québec - Santé
  • Canadian Statistical Sciences Institute

Cite

APA

Hagar, L., & Golchi, S. (2026). Design of Bayesian Clinical Trials With Clustered Data. Statistics in Medicine. https://doi.org/10.1002/sim.70488

Vancouver

Hagar L, Golchi S. Design of Bayesian Clinical Trials With Clustered Data. Statistics in Medicine. 2026. doi:10.1002/sim.70488

BibTeX
@article{Hagar2026,
  author = {Hagar, Luke and Golchi, Shirin},
  title = {Design of Bayesian Clinical Trials With Clustered Data},
  journal = {Statistics in Medicine},
  year = {2026},
  doi = {10.1002/sim.70488}
}
Start for free →